Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Interaction Map Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 262 to 311 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1867\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-soluble nsf attachment protein (snap-alpha) (n-ethylmaleimide- sensitive factor attachment protein, alpha). [source:swissprot;acc:p54920]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2722\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 1 isoform 2; lung alpha/beta hydrolase protein 1. [source:refseq;acc:nm\_152870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1134\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 3; lung alpha/beta hydrolase 3. [source:refseq;acc:nm\_138340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1132\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alveolar soft part sarcoma chromosome region, candidate 1; aspl protein; renal cell carcinoma gene on chromosome 17; renal cell carcinoma, papillary, 17 gene; aspscr1/tfe3 fusion gene, included. [source:refseq;acc:nm\_024083]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2829\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
amidophosphoribosyltransferase precursor (ec 2.4.2.14) (glutamine phosphoribosylpyrophosphate amidotransferase) (atase) (gpat). [source:swissprot;acc:q06203]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2550\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aminoacylase-1 (ec 3.5.1.14) (n-acyl-l-amino-acid amidohydrolase) (acy-1). [source:swissprot;acc:q03154]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2349\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8001.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8353.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aminoadipate-semialdehyde synthase; lysine-ketoglutarate reductase /saccharopine dehydrogenase; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase. [source:refseq;acc:nm\_005763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
818\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7543.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6807.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10804\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aminomethyltransferase, mitochondrial precursor (ec 2.1.2.10) (glycine cleavage system t protein) (gcvt). [source:swissprot;acc:p48728]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1545\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5945.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ammecr1 protein. [source:refseq;acc:nm\_015365]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1062\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
70\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
amyloid beta a4 precursor protein-binding family a member 1 (neuron- specific x11 protein) (neuronal munc18-1-interacting protein 1) (mint-1) (adapter protein x11alpha). [source:swissprot;acc:q02410]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
97\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3897.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2820.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3817\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
amyloid beta precursor protein-binding protein 1; amyloid protein-binding protein 1. [source:refseq;acc:nm\_003905]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1909\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7287.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6858.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
amyloid beta precursor protein-binding protein 2; amyloid beta precursor protein (cytoplasmic tail)-binding protein 2; protein interacting with app tail 1. [source:refseq;acc:nm\_006380]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3191\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2665\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8999.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8936.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
anaphase-promoting complex subunit 10; anaphase-promoting complex 10. [source:refseq;acc:nm\_014885]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1647\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6503.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06973\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
anaphase-promoting complex subunit 2; anaphase-promoting complex 2. [source:refseq;acc:nm\_013366]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1518\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9630.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10341.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07381\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
androgen-induced 1; cgi-103 protein; androgen induced protein. [source:refseq;acc:nm\_016108]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1969\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
angiomotin like 2; leman coiled-coil protein; angiomotin-like protein 2. [source:refseq;acc:nm\_016201]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1771\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6218.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5829.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06667\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
angiomotin. [source:refseq;acc:nm\_133265]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1770\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [source:refseq;acc:nm\_018685]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
24908.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19117\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ankyrin 2 (brain ankyrin) (ankyrin b) (ankyrin, nonerythroid). [source:swissprot;acc:q01484]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1533\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6350.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5916.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07344\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ankyrin 3 (ank-3) (ankyrin g). [source:swissprot;acc:q12955]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1532\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ankyrin-repeat family a protein 2 (rfxank-like 2). [source:swissprot;acc:q9h9e1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2713\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
995\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6328.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5778.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09516\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1005\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6329.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5780.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09497\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1692\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6165.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5767.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06904\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
135\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apical-like protein (apxl protein). [source:swissprot;acc:q13796]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
658\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6834.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6088.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12254\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
183\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29051\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
656\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6893.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6139.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apolipoprotein b-100 precursor (apo b-100) [contains: apolipoprotein b-48 (apo b-48)]. [source:swissprot;acc:p04114]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1644\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6186.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5782.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [source:swissprot;acc:p42574]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
949\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis antagonizing transcription factor. [source:refseq;acc:nm\_012138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
853\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4502.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4078.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
771\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7057.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7181.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [source:refseq;acc:nm\_032797]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1496\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6389.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5945.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07469\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1225\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6019.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5546.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08529\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin 4 (wch4) (mercurial-insensitive water channel) (miwc). [source:swissprot;acc:p55087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
523\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12117.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10640.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13887\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin 5. [source:swissprot;acc:p55064]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
524\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12117.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10640\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin-cd (aqp-cd) (water channel protein for renal collecting duct) (adh water channel) (aquaporin 2) (collecting duct water channel protein) (wch-cd). [source:swissprot;acc:p41181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
526\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12117.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10639.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin-chip (water channel protein for red blood cells and kidney proximal tubule) (aquaporin 1) (aqp-1) (urine water channel). [source:swissprot;acc:p29972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
528\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12111.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10635.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arf gtpase-activating protein git1 (g protein-coupled receptor kinase- interactor 1). [source:swissprot;acc:q9y2x7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2219\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6136.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5853.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0484\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2252\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6113.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5840.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04665\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
436\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7168.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6230.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15042\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginase 1 (ec 3.5.3.1) (liver-type arginase). [source:swissprot;acc:p05089]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6670.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6271.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6668.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6267.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginine-glutamic acid dipeptide (re) repeats; atrophin 1-like; arginine glutamic acid dipeptide re repeats. [source:refseq;acc:nm\_012102]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2278\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
993\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7121.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6499.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1123\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5857.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08927\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/